Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Grossmann

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Seminars in Oncology|February 1, 2012
Integration of next-generation sequencing into clinical practice: are we there yet?Alexander Kohlmann, Vera Grossmann, Torsten Haferlach
British Journal of Haematology|January 9, 2013
Next-generation sequencing - feasibility and practicality in haematologyAlexander Kohlmann, Vera Grossmann, Niroshan Nadarajah, et al.
Bioinformatics (Oxford, England)|February 26, 2011
R453Plus1Toolbox: an R/Bioconductor package for analyzing Roche 454 Sequencing dataHans-Ulrich Klein, Christoph Bartenhagen, Alexander Kohlmann, et al.
The Oncologist|April 24, 2020
Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene AmplificationDirk Hempel, Thomas Wieland, Beate Solfrank, et al.
Blood|February 15, 2012
Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemiaSusanne Schnittger, Ulrike Bacher, Torsten Haferlach, et al.
Haematologica|August 11, 2011
Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemiaVera Grossmann, Wolfgang Kern, Stefan Harbich, et al.
Genes, Chromosomes & Cancer|August 14, 2012
Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia casesClaudia Haferlach, Ulrike Bacher, Vera Grossmann, et al.
American Journal of Medical Genetics. Part A|October 21, 2009
"Essentially" pure trisomy 3q27 --> qter: further delineation of the partial trisomy 3q phenotypeVera Grossmann, Doris Müller, Wilfried Müller, et al.
Haematologica|April 19, 2012
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflowSusanne Schnittger, Ulrike Bacher, Christiane Eder, et al.
Plos One|February 6, 2013
Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 casesAnnette Fasan, Tamara Alpermann, Claudia Haferlach, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Seminars in Oncology|February 1, 2012
Integration of next-generation sequencing into clinical practice: are we there yet?Alexander Kohlmann, Vera Grossmann, Torsten Haferlach
British Journal of Haematology|January 9, 2013
Next-generation sequencing - feasibility and practicality in haematologyAlexander Kohlmann, Vera Grossmann, Niroshan Nadarajah, et al.
Bioinformatics (Oxford, England)|February 26, 2011
R453Plus1Toolbox: an R/Bioconductor package for analyzing Roche 454 Sequencing dataHans-Ulrich Klein, Christoph Bartenhagen, Alexander Kohlmann, et al.
The Oncologist|April 24, 2020
Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene AmplificationDirk Hempel, Thomas Wieland, Beate Solfrank, et al.
Blood|February 15, 2012
Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemiaSusanne Schnittger, Ulrike Bacher, Torsten Haferlach, et al.
Haematologica|August 11, 2011
Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemiaVera Grossmann, Wolfgang Kern, Stefan Harbich, et al.
Genes, Chromosomes & Cancer|August 14, 2012
Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia casesClaudia Haferlach, Ulrike Bacher, Vera Grossmann, et al.
American Journal of Medical Genetics. Part A|October 21, 2009
"Essentially" pure trisomy 3q27 --> qter: further delineation of the partial trisomy 3q phenotypeVera Grossmann, Doris Müller, Wilfried Müller, et al.
Haematologica|April 19, 2012
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflowSusanne Schnittger, Ulrike Bacher, Christiane Eder, et al.
Plos One|February 6, 2013
Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 casesAnnette Fasan, Tamara Alpermann, Claudia Haferlach, et al.
Pageof 4